Cassio Murilo Hidalgo Filho, Medical Oncologist and Thoracic Oncology Fellow at Dana-Farber Cancer Institute and Harvard Medical School, shared on LinkedIn:
“A pleasure to discuss tarlatamab treatment and toxicity management in small cell lung cancer with brilliant colleagues from Bosnia and Herzegovina and across the Balkans
Thank you for the kind invitation! Emir Sokolović.”
You can also read: ESTRO-EORTC Expert Guideline on Target Delineation and Radiotherapy for Stage I–III Small Cell Lung Cancer
